Skip to main content
Premium Trial:

Request an Annual Quote

Genicon, Novartis Genomics Institute Launch Broad Genomic Partnership

NEW YORK, Nov. 2 — Genicon Sciences has closed a deal to allow the Genomics Institute of the Novartis Research Foundation to use its proprietary Resonance Light Scattering technology, according to Genicon. 

The partners will cooperatively develop and commercialize the technology, which Genicon has designed for stable, highly sensitive signal generation and detection in a range of molecular assays.

By the terms of the deal, San Diego, Calif.-based Genicon also gets certain rights to GNF  microarray technologies, which the company will use to further develop their platform for use in mouse antibody assays and protein microarray kits.

The R&D partnership will be pooled so that each partner pays for its own research costs, and each retains rights to developments in its own products, said a company spokesperson. Under this arrangement, Genicon will retain rights for assay development, and GNS will maintain commercial drug development rights.

Other financial details of the partenrship, originally announced o Thursday, were not disclosed. 

According to Genicon, their RLS technique is highly specific and up to 1 million times more sensitive than fluorescence signaling technology, making it ideal for applications in gene sequencing, immunohistology and gene expression studies.

The company, which is privately held, promotes an “open access” business model, by which it partners with other companies to develop and improve its core technology without upfront contract fees, milestone payments or royalty fees

GNF director Peter Schultz said in a statement that the institute, also based in San Diego, plans to use the product in its forward mouse genetics research program.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.